Figure 2
Figure 2. Th17 cells play a role in the early stage of CD4-mediated GVHD. (A) Lethally irradiated (850 cGy) BALB/c mice were reconstituted with 5 × 106 WT B6 TCD-BM alone, or with TCD-BM and 106 nylon wool–passed (NWP) WT B6 T cells or IL-17−/− T cells. Data represent 3 combined experiments: mice either received TCD-BM only (n = 15; dotted line, black square), IL-17−/− T cells + TCD-BM (n = 30; gray line, gray triangles) or WT T cells + TCD-BM (n = 30; solid line, black squares). (B) Lethally irradiated BALB/c mice received 5 × 106 WT B6 TCD-BM and 0.5 × 106 CD4+ WT B6 T cells or IL-17−/− T cells. Data represent 4 combined experiments: mice received either TCD-BM only (n = 30) (dotted line, black square), IL-17−/− CD4+ T cells + TCD-BM (n = 35) or WT B6 CD4+ T cells + TCD-BM (n = 45), P < .04. (C) Lethally irradiated (1300 cGy) C3FeB6F1 mice were reconstituted with 5 × 106 WT B6 TCD-BM and 2 × 106 NWP T cells WT B6 T cells or IL-17−/− T cells. Data represent 2 combined experiments: mice received TCD-BM only (n = 10; dotted line, black square), IL-17−/− T cells + TCD-BM (n = 20; gray line, gray triangles) or WT T cells + TCD-BM (n = 20; solid line, black squares). (D) Lethally irradiated BALB/c mice were reconstituted with 5 × 106 WT B6 TCD-BM (n = 20; dotted line, black square), or 5 × 106 WT B6 TCD-BM + 0.5 × 106 A20 cells (n = 20; gray line, gray circles), and 0.5 × 106 NWP WT B6 T cells + 0.5 × 106 A20 cells (n = 40; solid line, black squares) or IL-17−/− T cells + 0.5 × 106 A20 cells (n = 40; gray line, gray triangles). Data represent 4 combined experiments. Survival curves are shown.

Th17 cells play a role in the early stage of CD4-mediated GVHD. (A) Lethally irradiated (850 cGy) BALB/c mice were reconstituted with 5 × 106 WT B6 TCD-BM alone, or with TCD-BM and 106 nylon wool–passed (NWP) WT B6 T cells or IL-17−/− T cells. Data represent 3 combined experiments: mice either received TCD-BM only (n = 15; dotted line, black square), IL-17−/− T cells + TCD-BM (n = 30; gray line, gray triangles) or WT T cells + TCD-BM (n = 30; solid line, black squares). (B) Lethally irradiated BALB/c mice received 5 × 106 WT B6 TCD-BM and 0.5 × 106 CD4+ WT B6 T cells or IL-17−/− T cells. Data represent 4 combined experiments: mice received either TCD-BM only (n = 30) (dotted line, black square), IL-17−/− CD4+ T cells + TCD-BM (n = 35) or WT B6 CD4+ T cells + TCD-BM (n = 45), P < .04. (C) Lethally irradiated (1300 cGy) C3FeB6F1 mice were reconstituted with 5 × 106 WT B6 TCD-BM and 2 × 106 NWP T cells WT B6 T cells or IL-17−/− T cells. Data represent 2 combined experiments: mice received TCD-BM only (n = 10; dotted line, black square), IL-17−/− T cells + TCD-BM (n = 20; gray line, gray triangles) or WT T cells + TCD-BM (n = 20; solid line, black squares). (D) Lethally irradiated BALB/c mice were reconstituted with 5 × 106 WT B6 TCD-BM (n = 20; dotted line, black square), or 5 × 106 WT B6 TCD-BM + 0.5 × 106 A20 cells (n = 20; gray line, gray circles), and 0.5 × 106 NWP WT B6 T cells + 0.5 × 106 A20 cells (n = 40; solid line, black squares) or IL-17−/− T cells + 0.5 × 106 A20 cells (n = 40; gray line, gray triangles). Data represent 4 combined experiments. Survival curves are shown.

Close Modal

or Create an Account

Close Modal
Close Modal